ARO TSLP
Alternative Names: ARO-TSLPLatest Information Update: 30 May 2024
At a glance
- Originator Arrowhead Pharmaceuticals
- Class Antiasthmatics; Small interfering RNA
- Mechanism of Action RNA interference; Thymic stromal lymphopoietin expression inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Allergic asthma